Publikationstyp: Working Paper – Gutachten – Studie
Titel: The chinese medtech sector with focus on new regulatory rules
Autor/-in: Mattes, Urs
Kaiser, Franc
Beswick, Richard
Haarmann, Jens
Umfang: 28
Erscheinungsdatum: 2017
Verlag / Hrsg. Institution: Switzerland Global Enterprise
Verlag / Hrsg. Institution: Zürich
Sprache: Englisch
Schlagwörter: Chinese Medtech; Switzerland global enterprise; Regulatory rule; Healthcare
Fachgebiet (DDC): 362: Gesundheits- und Sozialdienste
Zusammenfassung: Even though 95 per cent of the population is insured by basic medical insurance, the scheme does not address chronically ill patients who need long term treatment. China spends 5.8 per cent of its GDP on healthcare and the per capita expenditure is US$ 650, which is inadequate to provide for chronically ill patients. Since there is no gatekeeper in the Chinese healthcare system, the government is trying to channel patients to community health centers. The development of the private healthcare market is slow, because most doctors do not want to leave careers at public hospitals. Outbound medical tourism has reached a size of US$ 10 billion in 2015, as affluent people tend to avoid treatment in China. It seems obvious that in the future two different healthcare systems will coexist in China, namely: a large high-volume, low-priced public system and a small low-volume, high-priced private system. Since the large public system is controlled by the government, tender prices are bound to get lower.
Lizenz (gemäss Verlagsvertrag): Lizenz gemäss Verlagsvertrag
Departement: School of Management and Law
Organisationseinheit: Institut für Marketing Management (IMM)
Enthalten in den Sammlungen:Publikationen School of Management and Law

Dateien zu dieser Ressource:
Es gibt keine Dateien zu dieser Ressource.
Zur Langanzeige

Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.